OMV/ AT0000743059 /
2024-05-21 12:40:21 PM | Chg. -0.0200 | Volume | Bid1:13:02 PM | Ask1:08:20 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
47.8800EUR | -0.04% | 1,890 Turnover: 90,431 |
47.9200Bid Size: 700 | 48.0000Ask Size: 700 | 15.65 bill.EUR | 10.55% | 10.57 |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
2021-10-13
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
2021-07-28
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
euro adhoc
2021-06-07
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
2021-06-07
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
2021-06-02
EANS-Other capital market information: OMV Aktiengesellschaft / Acquisition and/or sale of treasury ...